A clinical trial to study the effect of two drugs, rohitakaabhaya kwatha and patolakaturohinyadi kwatha with diet advice in patients with yakrudalyudara(non alcoholic fatty liver disease)
Phase 2
- Conditions
- Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
- Registration Number
- CTRI/2022/02/039940
- Lead Sponsor
- All India Institute Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Non-alcoholic fatty liver disease patient, diagnosed by abdomen ultrasonic examination (grade I and II)
2.NAFLD confirmed by USG with or without having symptoms like fatigue, mild discomfort in the upper quadrant of abdomen
Exclusion Criteria
1.Pregnancy and weak patients
2.Any dysfunction of liver besides non-alcoholic fatty liver disease like hepatitis, liver cirrhosis
3.Liver Transplantation or Any other Condition Interfering with the result of the treatment.
4.Metabolic syndromes such as Type I and II diabetes mellitus, hypertension, thyroid dysfunctions
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method There will be remarkable change in Serum AST, ALT and Alkaline Phosphate level. It also decreases the enlargement of liver with correction of fatty changes in USG.Timepoint: 30 months
- Secondary Outcome Measures
Name Time Method Overall improvement in the quality of life. Improving agnibala of patient.Timepoint: 0th,15th,30th